Livzon Pharmaceutical Group Inc. LP6.F Stock
Livzon Pharmaceutical Group Inc. Price Chart
Livzon Pharmaceutical Group Inc. LP6.F Financial and Trading Overview
Livzon Pharmaceutical Group Inc. stock price | 3.14 EUR |
Previous Close | 3.24 EUR |
Open | 3.2 EUR |
Bid | 3.18 EUR x 300000 |
Ask | 3.42 EUR x 300000 |
Day's Range | 3.2 - 3.2 EUR |
52 Week Range | 2.42 - 3.36 EUR |
Volume | 1K EUR |
Avg. Volume | 17 EUR |
Market Cap | 4.11B EUR |
Beta (5Y Monthly) | 0.471575 |
PE Ratio (TTM) | 11.428572 |
EPS (TTM) | 0.28 EUR |
Forward Dividend & Yield | 0.21 (6.95%) |
Ex-Dividend Date | July 4, 2023 |
1y Target Est | N/A |
LP6.F Valuation Measures
Enterprise Value | -2870902016 EUR |
Trailing P/E | 11.428572 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.32709843 |
Price/Book (mrq) | 0.20840119 |
Enterprise Value/Revenue | -0.229 |
Enterprise Value/EBITDA | -1.104 |
Trading Information
Livzon Pharmaceutical Group Inc. Stock Price History
Beta (5Y Monthly) | 0.471575 |
52-Week Change | 6.84% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.36 EUR |
52 Week Low | 2.42 EUR |
50-Day Moving Average | 3.21 EUR |
200-Day Moving Average | 2.98 EUR |
LP6.F Share Statistics
Avg. Volume (3 month) | 17 EUR |
Avg. Daily Volume (10-Days) | 100 EUR |
Shares Outstanding | 309.83M |
Float | 502.67M |
Short Ratio | N/A |
% Held by Insiders | 52.72% |
% Held by Institutions | 13.97% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.6 |
Trailing Annual Dividend Yield | 49.38% |
5 Year Average Dividend Yield | 570.00% |
Payout Ratio | 0.6199 |
Last Split Factor | 13:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 15.42% |
Operating Margin (ttm) | 15.32% |
Gross Margin | 62.91% |
EBITDA Margin | 20.69% |
Management Effectiveness
Return on Assets (ttm) | 4.87% |
Return on Equity (ttm) | 12.90% |
Income Statement
Revenue (ttm) | 12.56B EUR |
Revenue Per Share (ttm) | 13.43 EUR |
Quarterly Revenue Growth (yoy) | -1.89% |
Gross Profit (ttm) | N/A |
EBITDA | 2.6B EUR |
Net Income Avi to Common (ttm) | 1.94B EUR |
Diluted EPS (ttm) | 0.28 |
Quarterly Earnings Growth (yoy) | 5.20% |
Balance Sheet
Total Cash (mrq) | 10.95B EUR |
Total Cash Per Share (mrq) | 11.78 EUR |
Total Debt (mrq) | 4.05B EUR |
Total Debt/Equity (mrq) | 26.27 EUR |
Current Ratio (mrq) | 2.429 |
Book Value Per Share (mrq) | 15.355 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.36B EUR |
Levered Free Cash Flow (ttm) | 113M EUR |
Profile of Livzon Pharmaceutical Group Inc.
Country | Germany |
State | N/A |
City | Zhuhai |
Address | Headquarters Building |
ZIP | 519090 |
Phone | 86 75 6813 5888 |
Website | https://www.livzon.com.cn |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 9005 |
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.
Q&A For Livzon Pharmaceutical Group Inc. Stock
What is a current LP6.F stock price?
Livzon Pharmaceutical Group Inc. LP6.F stock price today per share is 3.14 EUR.
How to purchase Livzon Pharmaceutical Group Inc. stock?
You can buy LP6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Livzon Pharmaceutical Group Inc.?
The stock symbol or ticker of Livzon Pharmaceutical Group Inc. is LP6.F.
Which industry does the Livzon Pharmaceutical Group Inc. company belong to?
The Livzon Pharmaceutical Group Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Livzon Pharmaceutical Group Inc. have in circulation?
The max supply of Livzon Pharmaceutical Group Inc. shares is 1.34B.
What is Livzon Pharmaceutical Group Inc. Price to Earnings Ratio (PE Ratio)?
Livzon Pharmaceutical Group Inc. PE Ratio is 11.21428600 now.
What was Livzon Pharmaceutical Group Inc. earnings per share over the trailing 12 months (TTM)?
Livzon Pharmaceutical Group Inc. EPS is 0.28 EUR over the trailing 12 months.
Which sector does the Livzon Pharmaceutical Group Inc. company belong to?
The Livzon Pharmaceutical Group Inc. sector is Healthcare.